Literature DB >> 20694785

Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation.

Xue-mei Gu1, Zhao-feng Jiang, Han-chang Huang.   

Abstract

Alzheimer's disease (AD) is a devastating late-life dementia that produces progressive loss of memory and mental faculties in elderly people. It is important to identify the earliest evidence of AD and to monitor the development of this disease for us to make positive response to its management. Magnetic resonance imaging (MRI) is powerful to image the tissue or organ without damnification. MRI can be employed to diagnose the early AD development and monitor the key biomarker development in AD. MRI may be helpful not only in diagnosing early AD, but also in evaluating its development. This article reviews the progress of MRI on the diagnosis and detection of AD, and makes comments on its therapeutic application.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694785     DOI: 10.1007/s11655-010-0276-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  32 in total

1.  Sodium MR imaging detection of mild Alzheimer disease: preliminary study.

Authors:  E A Mellon; D T Pilkinton; C M Clark; M A Elliott; W R Witschey; A Borthakur; R Reddy
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-12       Impact factor: 3.825

2.  Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y Xu; P C O'Brien; G E Smith; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

3.  Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy.

Authors:  H Benveniste; G Einstein; K R Kim; C Hulette; G A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Radiographic thin-section image of the human wrist by nuclear magnetic resonance.

Authors:  W S Hinshaw; P A Bottomley; G N Holland
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

5.  Multinuclear NMR studies on the energy metabolism of glial and neuronal cells.

Authors:  A Brand; C Richter-Landsberg; D Leibfritz
Journal:  Dev Neurosci       Date:  1993       Impact factor: 2.984

6.  Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus.

Authors:  Olivier Colliot; Gaël Chételat; Marie Chupin; Béatrice Desgranges; Benoît Magnin; Habib Benali; Bruno Dubois; Line Garnero; Francis Eustache; Stéphane Lehéricy
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

7.  Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.

Authors:  J W Pettegrew; K Panchalingam; J Moossy; J Martinez; G Rao; F Boller
Journal:  Arch Neurol       Date:  1988-10

8.  Principal component analysis with pre-normalization improves the signal-to-noise ratio and image quality in positron emission tomography studies of amyloid deposits in Alzheimer's disease.

Authors:  Pasha Razifar; Henry Engler; Gunnar Blomquist; Anna Ringheim; Sergio Estrada; Bengt Långström; Mats Bergström
Journal:  Phys Med Biol       Date:  2009-05-19       Impact factor: 3.609

9.  Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.

Authors:  Miroslaw Brys; Lidia Glodzik; Lisa Mosconi; Remigiusz Switalski; Susan De Santi; Elizabeth Pirraglia; Kenneth Rich; Byeong C Kim; Pankaj Mehta; Ray Zinkowski; Domenico Pratico; Anders Wallin; Henrik Zetterberg; Wai H Tsui; Henry Rusinek; Kaj Blennow; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

Review 10.  Role of huperzine a in the treatment of Alzheimer's disease.

Authors:  Alicia R Desilets; Jennifer J Gickas; Kaelen C Dunican
Journal:  Ann Pharmacother       Date:  2009-02-24       Impact factor: 3.154

View more
  3 in total

1.  Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy.

Authors:  Seyed Mojtaba Mashmoul Moghadam; Mona Alibolandi; Maryam Babaei; Jafar Mosafer; Amir Sh Saljooghi; Mohammad Ramezani
Journal:  J Biol Inorg Chem       Date:  2020-11-06       Impact factor: 3.358

Review 2.  Illuminating Neural Circuits in Alzheimer's Disease.

Authors:  Yang Ying; Jian-Zhi Wang
Journal:  Neurosci Bull       Date:  2021-06-05       Impact factor: 5.271

3.  The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.

Authors:  Ka-Kit Chua; Adrian Wong; Pauline Wing-Lam Kwan; Ju-Xian Song; Lei-Lei Chen; Andrew Lung-Tat Chan; Jia-Hong Lu; Vincent Mok; Min Li
Journal:  Trials       Date:  2015-04-30       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.